about
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its...
Read More
0.30
0.02
(7.14%)
1.3M
XNAS Volume
XNAS 16 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
Cue Biopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..